$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
英菲格拉替尼进医保了吗,药物不良反应是什么?
2025-10-19 11:44:20
Check Details
英菲格拉替尼疗效怎么样,有副作用吗?
2025-10-19 11:44:20
Check Details
英菲格拉替尼怎么吃,需要注意什么?
2025-10-19 11:44:20
Check Details
英菲格拉替尼有耐药性吗,副作用大吗?
2025-10-19 11:44:20
Check Details
艾伏尼布多久会耐药,应该怎么处理?
2025-10-19 11:44:20
Check Details
艾伏尼布一天吃几次,可以服用多久?
2025-10-19 11:44:20
Check Details
艾伏尼布副作用是什么,需要注意哪些事项?
2025-10-19 11:44:20
Check Details
英菲格拉替尼的副作用是什么,多久一个疗程?
2025-10-19 11:44:20
Check Details
抗癌新特药英菲格拉替尼有什么副作用?国内纳入医保了吗?
2025-10-19 11:44:20
Check Details
你知道培美替尼的功效及副作用吗?
2025-10-19 11:44:20
Check Details
Incyte公司的培美替尼副作用处理方法
2025-10-19 11:44:20
Check Details
英菲格拉替尼副作用多不多?治疗时要注意什么
2025-10-19 11:44:20
Check Details
1
2
...
36
37
38
39
40
41
42
...
4159
4160
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Belzutifan (WELIREG) Treatment Guide: Duration, Onset of Action, and Monitoring Protocol
2
Lapatinib Side Effects: Managing Diarrhea, Skin Reactions, and Liver Function Changes
3
Cemiplimab: A PD-1 Checkpoint Inhibitor for Skin Cancers and Non-Small Cell Lung Cancer
4
Capmatinib (Tabrecta): Generational Positioning, Adverse Effect Incidence, and Comprehensive Management
5
Dabrafenib (TAFINLAR): Indications, Adverse Effect Management, and Dose Modification Guide
6
Adagrasib (Krazati): A Complete Guide to Side-Effect Recognition and Grade-Based Management
7
Tepotinib (TEPMETKO): Complete Dosing, Side-Effect Management, and Discontinuation Guide
8
Tivozanib Dosage and Administration: Standard Dosing, Cycle Schedule, and Hepatic Impairment Adjustments
9
Vemurafenib: Mechanism of Action and Clinical Role in BRAF V600E–Targeted Therapy
10
Sotorasib (Lumakras): A Comprehensive Guide to the First KRAS G12C-Targeted Inhibitor
11
Comprehensive Interpretation of Osimertinib: Efficacy, Side Effects and Medication Standards
12
Sotorasib: Can the First KRAS G12C-Targeted Therapy Cure Cancer?